Arthur J. Gallagher & Co.

  • Market Cap: Large Cap
  • Industry: Capital Markets
  • ISIN: US3635761097
USD
245.41
0.05 (0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Arthur J. Gallagher & Co. stock-summary
stock-summary
Arthur J. Gallagher & Co.
Capital Markets
Arthur J. Gallagher & Co. and its subsidiaries are engaged in providing insurance brokerage and consulting services, and third-party claims settlement and administration services to both domestic and international entities. The Company operates through three segments: brokerage, risk management and corporate. The brokerage segment primarily consists of retail and wholesale insurance brokerage operations. Its retail brokerage operations negotiate and place property/casualty, employer-provided health and welfare insurance, and healthcare exchange and retirement solutions principally for middle-market commercial, industrial, public entity, religious and not-for-profit entities. The risk management segment provides contract claim settlement and administration services for enterprises that choose to self-insure some or all of their property/casualty coverages and for insurance companies that choose to outsource some or all of their property/casualty claims departments.
Company Coordinates stock-summary
Company Details
250 PARK AVENUE, FIFTH FLOOR , NEW YORK NY : 10177
stock-summary
Tel: 1 212 91896851 630 2853661
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 163 Schemes (41.47%)

Foreign Institutions

Held by 418 Foreign Institutions (22.99%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. J. Patrick Gallagher
Chairman of the Board, Chief Executive Officer
Mr. David Johnson
Lead Independent Director
Mrs. Sherry Barrat
Independent Director
Mr. William Bax
Independent Director
Mr. David Coldman
Independent Director
Mr. Frank English
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3,221 Million
(Quarterly Results - Jun 2025)
Net Profit:
366 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 76,694 Million (Large Cap)

stock-summary
P/E

52.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.80%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

7.24%

stock-summary
Price to Book

3.33